SAGE Publications
Multiple Sclerosis Journal - Experimental, Translational and Clinical
In PubMed through PubMed Central. Fully open access. Published by SAGE Publications.
Publishing in Multiple Sclerosis Journal - Experimental, Translational and Clinical
Multiple Sclerosis Journal Experimental, Translational and Clinical publishes open access research across experimental, translational and clinical multiple sclerosis. Its scope includes emerging findings with translational potential, early validation of clinical outcome measures, pilot trials, geographically focused validation and specialised research topics.
The journal accepts original research, systematic and traditional reviews, case and short reports, letters, viewpoints, future perspectives, editorials, and invited book and meeting reviews. Every accepted article carries an article processing charge, although institutional discounts and waivers may apply, and there is no submission fee. The median first decision is six days, the acceptance rate is 45.3%, and peer review is single anonymised.
Free subscriber access
Free with a subscription: the author guide in one place
Word limits, abstract lengths and fees for each article type, and a checklist before you submit. Enter your email to unlock this journal and every other guide.
You'll also receive The Weekend Round every Saturday.- Original research paper
Original experimental, translational or clinical research with a structured abstract.
- Words
- 3,000
- Abstract
- 200
- Figures & tables
- —
- References
- 35
- Systematic reviews and meta-analyses
Critical reviews of clinically or scientifically important topics following PRISMA or MOOSE.
- Words
- 4,000
- Abstract
- 200
- Figures & tables
- —
- References
- 45
- Traditional review
Narrative reviews of topics relevant to multiple sclerosis research and care.
- Words
- 3,500
- Abstract
- 200
- Figures & tables
- —
- References
- 45
- Case report or short report
Brief reports illustrating an important clinical or scientific point.
- Words
- 1,000
- Abstract
- 100
- Figures & tables
- 2
- References
- 10
- Letter to the Editor
Brief correspondence on published papers or other topics relevant to the journal.
- Words
- 500
- Abstract
- —
- Figures & tables
- —
- References
- 5
- Personal viewpoint
Discussion pieces offering new ideas or questioning significant multiple sclerosis research.
- Words
- 1,500
- Abstract
- —
- Figures & tables
- 2
- References
- 10
- Future perspective
Group perspectives on improving or updating important areas of multiple sclerosis research.
- Words
- 1,500
- Abstract
- —
- Figures & tables
- 2
- References
- 10
- Editorial
Invited commentary on topics connected with papers in an issue.
- Words
- 1,000
- Abstract
- —
- Figures & tables
- —
- References
- 10
- Book and meeting review
Invited reviews of relevant books and scientific meetings.
- Words
- —
- Abstract
- —
- Figures & tables
- —
- References
- —
The article processing charge is US$3,200 plus VAT where applicable. Institutional discounts and full or partial waivers may be available. There is no submission charge.
Before you submit
- Upload the relevant EQUATOR reporting checklist with the manuscript.
- Register clinical trials before first participant enrolment and include registry details in the abstract.
- Use a structured abstract of no more than 200 words for original research.
- Remove identifying details from the manuscript and provide them on a separate title page.
- Submit tables as separate Word files and figures as separate image files.
Present it first.
Similar journals.
Frequently asked
- Is Multiple Sclerosis Journal - Experimental, Translational and Clinical indexed in PubMed?
- Yes, through PubMed Central. Its articles are deposited in PMC and appear in PubMed with a PMID; it is not indexed in MEDLINE.
- How much does it cost to publish in Multiple Sclerosis Journal - Experimental, Translational and Clinical?
- Not stated by the journal.
- Does Multiple Sclerosis Journal - Experimental, Translational and Clinical accept case reports?
- Yes. Multiple Sclerosis Journal - Experimental, Translational and Clinical publishes case reports.
- What is the Impact Factor of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
- Multiple Sclerosis Journal - Experimental, Translational and Clinical states an Impact Factor of 2 for 2025.
- How long does Multiple Sclerosis Journal - Experimental, Translational and Clinical take to decide?
- About 6 days from submission to first decision.
- What is the acceptance rate of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
- Multiple Sclerosis Journal - Experimental, Translational and Clinical states that it accepts 45.3% of submissions.
- What kind of peer review does Multiple Sclerosis Journal - Experimental, Translational and Clinical use?
- Single-blind peer review.
PubMed via PMC · Open access · First decision in 6 days
- Accepted work
- Original research · Case report · Systematic review · Literature review
- Acceptance rate
- 45.3%
- Peer review
- Single-blind
- Access
- Free to read
Checked against the journal’s author guide · updated 15 Nov 2026








